Search Within

Elizabeth Siryeon Won

  1. "MSK Grad Students"
Formats
  1. Journal Article (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (5)
  2. Center for Pancreatic Cancer Research (5)
  3. Computational Oncology Service (5)
  4. Department of Medicine (5)
  5. Epidemiology and Biostatistics (5)
  6. GSK Faculty (5)

More Groups

People
  1. Avni Desai (3)
  2. David Ilson (3)
  3. Geoffrey Ku (3)
  4. Laura Tang (3)
  5. Nikolaus Schultz (3)
  6. Parisa Momtaz (3)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (1)
  4. 2020 (1)
  5. 2019 (1)
Publications
  1. Nature (2)
  2. Clinical Cancer Research (1)
  3. JNCI: Journal of the National Cancer Institute (1)
  4. Lancet Oncology (1)
Publishers
  1. Nature Publishing Group (2)
  2. American Association for Cancer Research (1)
  3. Elsevier Science, Inc. (1)
  4. Oxford University Press (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
    Journal Article

    Sethna, Z.; Guasp, P.; Reiche, C.; Milighetti, M.; Ceglia, N.; Patterson, E.; Lihm, J.; Payne, G.; Lyudovyk, O.; Rojas, L. A.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
    Journal Article

    Lumish, M. A.; Walch, H.; Maron, S. B.; Chatila, W.; Kemel, Y.; Maio, A.; Ku, G. Y.; Ilson, D. H.; Won, E.; Li, J.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
    Journal Article

    Rojas, L. A.; Sethna, Z.; Soares, K. C.; Olcese, C.; Pang, N.; Patterson, E.; Lihm, J.; Ceglia, N.; Guasp, P.; Chu, A.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy of combined VEGFR1-3, PDGFα/β, and FGFR1-3 blockade using nintedanib for esophagogastric cancer
    Journal Article

    Won, E.; Basunia, A.; Chatila, W. K.; Hechtman, J. F.; Chou, J. F.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save